These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37312528)
1. NRF2/HO-1 axis, BIRC5, and TP53 expression in ESCC and its correlation with clinical pathological characteristics and prognosis. Gao Y; Wan L; Li M; Wang B; Ma Y Int J Biol Markers; 2023 Dec; 38(3-4):174-184. PubMed ID: 37312528 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of Nrf2/HO-1 expression and its correlation with occurrence in esophageal squamous cell carcinoma. Gao Y; Li M; Wang B; Ma Y Genes Genomics; 2023 Jun; 45(6):723-739. PubMed ID: 37043130 [TBL] [Abstract][Full Text] [Related]
3. Blockage of Nrf2 suppresses the migration and invasion of esophageal squamous cell carcinoma cells in hypoxic microenvironment. Shen H; Yang Y; Xia S; Rao B; Zhang J; Wang J Dis Esophagus; 2014; 27(7):685-92. PubMed ID: 24028437 [TBL] [Abstract][Full Text] [Related]
5. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma. Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732 [TBL] [Abstract][Full Text] [Related]
7. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis. Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242 [TBL] [Abstract][Full Text] [Related]
8. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. Chen ZX; Li GS; Yang LH; Liu HC; Qin GM; Shen L; He WY; Gan TQ; Li JJ Math Biosci Eng; 2021 Aug; 18(5):6941-6960. PubMed ID: 34517565 [TBL] [Abstract][Full Text] [Related]
10. Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma. Peng H; Yao S; Dong Q; Zhang Y; Gong W; Jia Z; Yan L Medicine (Baltimore); 2018 Aug; 97(31):e11697. PubMed ID: 30075571 [TBL] [Abstract][Full Text] [Related]
11. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence]. Wang X; Wang Z; Lu WL; Zhao GF Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237 [No Abstract] [Full Text] [Related]
12. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma]. Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216 [TBL] [Abstract][Full Text] [Related]
13. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma. Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748 [TBL] [Abstract][Full Text] [Related]
14. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression. Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221 [TBL] [Abstract][Full Text] [Related]
15. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2. Han M; Li N; Li F; Wang H; Ma L Hum Cell; 2020 Jul; 33(3):641-651. PubMed ID: 32419118 [TBL] [Abstract][Full Text] [Related]
16. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Lv J; Cao XF; Ji L; Zhu B; Wang DD; Tao L; Li SQ Med Oncol; 2012 Mar; 29(1):151-60. PubMed ID: 21259057 [TBL] [Abstract][Full Text] [Related]
17. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance. Wang Z; Zhang J; Li M; Kong L; Yu J Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma. Liu L; Lu Z; Hu X; Su T; Su L; Pu H Medicine (Baltimore); 2021 Jul; 100(28):e26597. PubMed ID: 34260541 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma. Wei R; Shang Z; Leng J; Cui L J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242 [TBL] [Abstract][Full Text] [Related]
20. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features. Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]